Tue, Jul 29, 2014, 6:18 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Itron, Inc. Message Board

rightofway2004 2 posts  |  Last Activity: Jun 28, 2014 12:07 AM Member since: Jul 14, 2004
  • rightofway2004 by rightofway2004 Jun 28, 2014 12:07 AM Flag

    It appears we are entering into the third week of a flag pattern. Volume drop and price indicators over that time seems to confirm this. If my reading of the tea leaves is correct I believe we are on the verge of the next leg up which should put us at 15+. That should happen in the next week or two. I bought the stock because of its fundamentals but I'm trying to learn how to read technical indicators so let's see if I'm right.

  • rightofway2004 by rightofway2004 Jun 21, 2014 2:58 PM Flag

    According to Sirgo in the Wells Fargo call. "We are staring at a billion dollar pipeline". Says they are very optimistic of a positive buprenorphine readout. If it happens, the street will assume approval and begin to price in the market opportunity. Also sounds like the will increase the market opportunity over the current $500mm target when other competing products move to schedule 2 opiods. At 2% of the pain market they will be over $1B at mid to upper teen royalty that would be $150mm of added revenue with little to no cost. If Bunivail gets to $250mm and this goes to $150mm then, assuming $100mm in costs and taxes, they are at $300mm earnings or $6 per share. At a PE of 20 (ultra conservative in my opinion for a growing biotech company) they get to $120 per share. At 40 PE (also not out of the realm of possibility see Salix) this gets to $240 per share.

36.33-0.37(-1.01%)Jul 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.